Context Therapeutics Receives Nasdaq Noncompliance Notice, Gets Time Through Jan. 25 To Regain Compliance

Benzinga Newsdesk www.benzinga.com Neutral 92.9%

Neg 0% Neu 92.9% Pos 0%

https://www.sec.gov/ix?doc=/Archives/edgar/data/1842952/000162828026051399/cntx-20260729.htm

Comments

No comments yet. Be the first!